ReviewExpert opinion on investigational drugs2021
The time to offer treatments for COVID-19.
Open access · greenAbstract readReview
In one paragraph
Review in Expert opinion on investigational drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 32 citations in OpenAlex.
- Review
- Neuroinflammatory and transcriptional dynamics during SARS-CoV-2 infection in KRT18-hACE2 mouse brain.Frontiers in immunology · 2026Article
- Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia.Biomedicines · 2024Review
- A Prospective 1-Year Follow-up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection.Diabetes & metabolism journal · 2024Article
- The Value of Ursodeoxycholic Acid and Mesenchymal Stem Cells in the Treatment of Severe COVID-19.Microorganisms · 2024Article
- Investigating the trend of demographic changes, mortality, clinical and paraclinical findings of patients hospitalized in the Corona ward, before and after the start of general vaccination of COVID-19.BMC infectious diseases · 2024Article
- Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out.Diseases (Basel, Switzerland) · 2023Review
- A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors.Endocrine · 2023Article
- Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong.JAMA network open · 2023Article
- From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023Review
- Article
- Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19.Frontiers in immunology · 2023Review
- Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells.Nature communications · 2022Article
- Oral antivirals for the prevention and treatment of SARS-CoV-2 infection.AIDS reviews · 2022Article
- Bacterial infections in patients hospitalized with COVID-19.Internal and emergency medicine · 2022Article
- Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022Article
- Combination therapies for COVID-19: An overview of the clinical trials landscape.British journal of clinical pharmacology · 2022Review
- Therapeutics for COVID-19 and post COVID-19 complications: An update.Current research in pharmacology and drug discovery · 2022Review
- Article
- Third wave of COVID-19 in Madrid, Spain.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
37 authors at 16 institutions in 6 countries.
Binh T NgoKeck USC School of Medicine, Los Angeles, USA.
Paul MarikDepartment of Internal Medicine, Eastern Virginia Medical School, Pulmonary and Critical Care Medicine, Norfolk, USA.
Pierre KoryPulmonary and Critical Care Medicine, Aurora St. Luke's Medical Center, Milwaukee, USA.
Leland ShapiroDepartment of Internal Medicine, Rocky Mountain Regional Veterans Affairs Medical Center in Aurora, CO and University of Colorado Anschutz Medical Campus in Aurora, CO Supported by the Emily Foundation, Boston, USA.
Raphael ThomadsenDepartment of Marketing, Washington University, St. Louis, USA.
Jose IglesiasDepartment of Internal Medicine, Jersey Shore University Medical Center, Hackensack Meridian School of Medicine at Seton Hall, Neptune, USA.
Stephen DitmoreHealth Reporting, Parkchester Times, USA.
Marc RendellThe Rose Salter Medical Research Foundation, Newport Coast, USA.
Joseph VaronUnited Memorial Medical Center, University of Texas School of Medicine, Houston, USA.
Michael DubéKeck USC School of Medicine, Los Angeles, USA.
Neha NandaKeck USC School of Medicine, Los Angeles, USA.
Gino InKeck USC School of Medicine, Los Angeles, USA.
Daniel ArkfeldKeck USC School of Medicine, Los Angeles, USA.
Preet ChaudharyKeck USC School of Medicine, Los Angeles, USA.
Vito M CampeseKeck USC School of Medicine, Los Angeles, USA.
Diana L HannaKeck USC School of Medicine, Los Angeles, USA.
David E SawcerKeck USC School of Medicine, Los Angeles, USA.
Glenn EhresmannKeck USC School of Medicine, Los Angeles, USA.
David PengKeck USC School of Medicine, Los Angeles, USA.
Miroslaw SmogorewskiKeck USC School of Medicine, Los Angeles, USA.
April ArmstrongKeck USC School of Medicine, Los Angeles, USA.
Rajkumar DasguptaKeck USC School of Medicine, Los Angeles, USA.
Fred SattlerKeck USC School of Medicine, Los Angeles, USA.
Denise Brennan-RiederCoronaTracker Community Research Group, Canada.
Cristina MussiniDepartment of Infectious Disease, University of Modena and Reggio Emilia, Modena, Italy.
Oriol MitjaDepartment of Internal Medicine, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
Vicente SorianoDirector, Centro Medico, UNIR Health Sciences School & Medical Center, Madrid, Spain.
Nicolas PeschanskiDepartment of Emergency Medicine, UniversityHospital of Rennes, Rennes, France.
Gilles HayemDepartment of Rheumatology, Hôpital Paris Saint-Joseph, Paris, France.
Marco ConfalonieriDepartment of Respiratory Diseases, Azienda Ospedaliero-Universitaria Di Trieste, Trieste, Italia.
Maria Carmela PiccirilloDepartment of Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italia.
Antonio Lobo-FerreiraUnidade De Investigação Cardiovascular (Unic), Faculdade De Medicina, Da Universidade Do Porto, Centro Hospitalar Universitário De São João, Porto, and Hospital Rainha Santa Isabel, Marco De Canaveses, Portugal.
Iraldo Bello RiveroDepartment of Clinical Investigations, Center for Genetic Engineering and Biotechnology, Havana, Cuba.
Mika TurkiaQualitative Research, Helsinki, Finland.
Eivind H VinjevollDepartment of Anesthesiology, Volda Hospital HMR, Norway.
Daniel GriffinDepartment of Internal Medicine, Rocky Mountain Regional Veterans Affairs Medical Center in Aurora, CO and University of Colorado Anschutz Medical Campus in Aurora, CO Supported by the Emily Foundation, Boston, USA.
Ivan Fn HungDepartment of Internal Medicine, Rocky Mountain Regional Veterans Affairs Medical Center in Aurora, CO and University of Colorado Anschutz Medical Campus in Aurora, CO Supported by the Emily Foundation, Boston, USA.ORCID https://orcid.org/0000-0002-1556-2538
Keck Hospital of USC · USRocky Mountain MS Center · USAurora St. Luke's Medical Center · USAzienda Sanitaria Universitaria Integrata di Trieste · ITCentre Hospitalier Universitaire de Rennes · FRCentro de Ingeniería Genética y Biotecnología · CUEastern Virginia Medical School · USHôpital Paris Saint-Joseph · FRHospital Universitari Germans Trias i Pujol · ESIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITJersey Shore University Medical Center · USMemorial Medical Center · USNew York Times · USUniversity of Modena and Reggio Emilia · ITVolda University College · NOWashington University in St. Louis · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Ambulatory CareAntibodies, MonoclonalCOVID-19COVID-19 Drug TreatmentCOVID-19 SerotherapyCOVID-19 VaccinesHospitalizationHumansImmunization, PassiveRandomized Controlled Trials as TopicTime FactorsAntibodies, MonoclonalCOVID-19 Vaccinesconvalescent plasmacovid-19favipiravirhcqinterferon-β-1interferon-λivermectinremdesivirSARS-Cov-2synthetic anti-spike protein antibodies
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.